ALKERMES | ALKS - 债务

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 8.07B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	债务	更改		日
AbbVie	USD 72.86B		5.36B	2026-03
Acadia Pharmaceuticals	USD 50.79M		1.39M	2026-03
ALKERMES	USD 1.58B		1.51B	2026-03
Amgen	USD 57.32B		2.72B	2026-03
Biogen	USD 8.09B		1.53B	2026-06
BioMarin Pharmaceutical	USD 1.44B		833.74M	2026-03
Bristol-Myers Squibb	USD 46.43B		711M	2026-03
Coherus Biosciences	USD 294.92M		1.25M	2025-03
Eli Lilly	USD 43.37B		867M	2026-03
Gilead Sciences	USD 22.17B		2.76B	2026-03
Heron Therapeutics	USD 149.65M		157K	2024-09
Ionis Pharmaceuticals	USD 1.91B		425.5M	2026-06
J&J	USD 54.99B		7.05B	2026-03
Malin Corporation	EUR 100K		0	2023-12
Merck	USD 49.12B		222M	2026-03
Minerva Neurosciences	USD 0		0	2024-09
Nektar Therapeutics	USD 0		0	2022-06
Neurocrine Biosciences	USD 406.2M		9.1M	2026-03
Otsuka Holdings	JPY 227.98B		16.47B	2025-12
Ovoca Bio	EUR 0		0	2021-06
Pfizer	USD 63.19B		536M	2026-06
Regeneron Pharmaceuticals	USD 2.71B		400K	2026-06
Vertex Pharmaceuticals	USD 1.98B		8.9M	2026-06